Missoula, Montana, April 5, 2007 - Premium nutraceutical ingredient manufacturer TSI Health Sciences has been awarded a Nutrition Business Journal (NBJ) 'Investment in the Future' award based on the company's commitment in building high quality manufacturing facilities in China, representing an ongoing evolution in the company’s activities over the past ten years. The increased commitment specifically recognized with this award includes a wholly owned 60-acre operations hub, located at a progressive industrial park in Jiangyin with synthesis, hydrogenation and enzymatic extraction facilities, 35,000 square feet of Q/A and Q/C labs and international cGMP accreditation.
TSI also has two majority-owned cGMP JV facilities in China: TSI-Xuzhou Natural Products Co. Ltd. for large-scale botanical extraction, and TSI-Yangzhou Natural Products Co. Ltd. for glucosamine manufacturing.
The award will be presented in a ceremony at the NBJ Newport Summit in Laguna Niguel, Calif., July 18-20, 2007.
"We're honored to receive this award. Our commitment to reinvesting in our manufacturing operations, processes and capabilities is at the core of our philosophy, and we believe, a significant differentiator," observed Larry Kolb, TSI Health Sciences president, U.S. operations. "This investment is critical to ongoing market expansion, and our continuous pursuit of international certifications that position us in the top tier of ingredient manufacturers across the globe. We feel these investments offer significant long-term benefits to our strategic customers."
TSI Health Sciences
TSI Health Sciences, www.tsiinc.com, has evolved throughout the last decade to focus primarily on in-house, high-end ingredient production and has become a leading developer, producer and marketer of nutraceutical ingredients to the dietary supplement, pharmaceutical and food and beverage industries. With US operations based in Missoula, Mont., TSI was founded in 1996 and has offices worldwide, including a 60-acre, fully integrated manufacturing, research, quality assurance and quality control campus in Jiangyin, China. The company's comprehensive product range includes botanical, marine and natural product extracts, as well as synthesized compounds. TSI guarantees full-service cGMP manufacturing through TSI Manufacturing Systems, with divisions specializing in small and large-scale botanical and natural product extraction, large-scale chemical synthesis production and secondary processing capabilities.
# # #
For more information, contact:
Larry Kolb, President